Avinash Pagdhune
Avinash Pagdhune has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ankit Sheth
ICMR – National Institute of Occupational Health, Ahmedabad, India
1 shared publication - Ankit Viramgami
ICMR – National Institute of Occupational Health, Ahmedabad, India
1 shared publication Bidisa Sarkar
Department of General Medicine, KPC Medical College & Hospital, Kolkata, West Bengal, India
1 shared publicationJaseer C.J. Muhamed
Division of Biochemistry, ICMR-National Institute of Occupational Health, Ahmedabad, Gujarat, India
1 shared publication- Kamalesh Sarkar
ICMR-National Institute of Occupational Health, Ahmedabad, Gujarat, India
1 shared publication Nibedita Naha
Division of Biochemistry, ICMR-National Institute of Occupational Health, Ahmedabad, Gujarat, India
1 shared publication
Latest Publications
- Open Access
- 30 August 2024
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 29
Study association of urinary Club Cell Protein with air pollution-related pulmonary function compromised among children
- 30 August 2024
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 29
Open AccessStudy association of urinary Club Cell Protein with air pollution-related pulmonary function compromised among children
- Open Access
- 1 April 2020
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 151 (4) , 319-325
Club cell protein 16 as a biomarker for early detection of silicosis
Background & objectives: Clinically silicosis is diagnosed by chest X-ray showing specific opacities along with history of silica dust exposure. Diagnosis is invariably made at an advanced or end stage when it is irreversible. Moreover, silicosis patients are susceptible to develop tuberculosis. Therefore, a suitable biomarker for early detection of silicosis is needed. This study evaluated the suitability of club cell protein (CC16) as a biomarker for early detection of silicosis. Methods: This pilot study included 121 individuals from X-ray-confirmed/advanced silicosis, moderate silica dust-exposed workers and healthy controls from western India. CC16 levels were quantified in serum samples through ELISA. Sensitivity and specificity of CC16 values at different cut-off points were calculated in both non-smokers and smokers. Results: Serum CC16 level was significantly (P<0.01) decreased in X-ray confirmed advanced silicosis patients (4.7±3.07 ng/ml) followed by moderately exposed workers (10.2±1.77 ng/ml) as compared to healthy non-exposed individuals (16.7±3.81 ng/ml). Tobacco smoking also caused a significant decrease of serum CC16 concentration in both healthy (10.2±1.12 ng/ml) and advanced silicosis workers (2.6±2.28 ng/ml) compared to non-smokers. Sensitivity and specificity of CC16 values were also found to be ≥83 per cent for screening all categories of individuals. Interpretation & conclusions: Because of high sensitivity and specificity, serum CC16 could be used as predictive biomarker for suspicion and early detection of silicosis, which would help in reducing/delaying premature deaths caused by silicosis. It would also control silicotuberculosis additionally.
- 1 April 2020
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 151 (4) , 319-325
Open AccessClub cell protein 16 as a biomarker for early detection of silicosis
Background & objectives: Clinically silicosis is diagnosed by chest X-ray showing specific opacities along with history of silica dust exposure. Diagnosis is invariably made at an advanced or end stage when it is irreversible. Moreover, silicosis patients are susceptible to develop tuberculosis. Therefore, a suitable biomarker for early detection of silicosis is needed. This study evaluated the suitability of club cell protein (CC16) as a biomarker for early detection of silicosis. Methods: This pilot study included 121 individuals from X-ray-confirmed/advanced silicosis, moderate silica dust-exposed workers and healthy controls from western India. CC16 levels were quantified in serum samples through ELISA. Sensitivity and specificity of CC16 values at different cut-off points were calculated in both non-smokers and smokers. Results: Serum CC16 level was significantly (P<0.01) decreased in X-ray confirmed advanced silicosis patients (4.7±3.07 ng/ml) followed by moderately exposed workers (10.2±1.77 ng/ml) as compared to healthy non-exposed individuals (16.7±3.81 ng/ml). Tobacco smoking also caused a significant decrease of serum CC16 concentration in both healthy (10.2±1.12 ng/ml) and advanced silicosis workers (2.6±2.28 ng/ml) compared to non-smokers. Sensitivity and specificity of CC16 values were also found to be ≥83 per cent for screening all categories of individuals. Interpretation & conclusions: Because of high sensitivity and specificity, serum CC16 could be used as predictive biomarker for suspicion and early detection of silicosis, which would help in reducing/delaying premature deaths caused by silicosis. It would also control silicotuberculosis additionally.